Market Intelligence chevron_right Chemical & Material chevron_right Semisolid Dosage Form
Global Report 2024

Global Semisolid Dosage Form Market Growth 2024-2030

calendar_todayPublished: Jun 2024 descriptionPages: 151 categoryCategory: Chemical & Material
1 Scope of the Report

    1.1 Market Introduction

    1.2 Years Considered

    1.3 Research Objectives

    1.4 Market Research Methodology

    1.5 Research Process and Data Source

    1.6 Economic Indicators

    1.7 Currency Considered

    1.8 Market Estimation Caveats

2 Executive Summary

    2.1 World Market Overview

        2.1.1 Global Semisolid Dosage Form Annual Sales 2019-2030

        2.1.2 World Current & Future Analysis for Semisolid Dosage Form by Geographic Region, 2019, 2023 & 2030

        2.1.3 World Current & Future Analysis for Semisolid Dosage Form by Country/Region, 2019, 2023 & 2030

    2.2 Semisolid Dosage Form Segment by Type

        2.2.1 Ointments

        2.2.2 Pastes

        2.2.3 Plasters

        2.2.4 Gels

        2.2.5 Rigid Foams

    2.3 Semisolid Dosage Form Sales by Type

        2.3.1 Global Semisolid Dosage Form Sales Market Share by Type (2019-2024)

        2.3.2 Global Semisolid Dosage Form Revenue and Market Share by Type (2019-2024)

        2.3.3 Global Semisolid Dosage Form Sale Price by Type (2019-2024)

    2.4 Semisolid Dosage Form Segment by Application

        2.4.1 Skin

        2.4.2 Nasal Cavity

        2.4.3 Vaginal Cavity

        2.4.4 Rectal Cavity

        2.4.5 Others

    2.5 Semisolid Dosage Form Sales by Application

        2.5.1 Global Semisolid Dosage Form Sale Market Share by Application (2019-2024)

        2.5.2 Global Semisolid Dosage Form Revenue and Market Share by Application (2019-2024)

        2.5.3 Global Semisolid Dosage Form Sale Price by Application (2019-2024)

3 Global Semisolid Dosage Form by Company

    3.1 Global Semisolid Dosage Form Breakdown Data by Company

        3.1.1 Global Semisolid Dosage Form Annual Sales by Company (2019-2024)

        3.1.2 Global Semisolid Dosage Form Sales Market Share by Company (2019-2024)

    3.2 Global Semisolid Dosage Form Annual Revenue by Company (2019-2024)

        3.2.1 Global Semisolid Dosage Form Revenue by Company (2019-2024)

        3.2.2 Global Semisolid Dosage Form Revenue Market Share by Company (2019-2024)

    3.3 Global Semisolid Dosage Form Sale Price by Company

    3.4 Key Manufacturers Semisolid Dosage Form Producing Area Distribution, Sales Area, Product Type

        3.4.1 Key Manufacturers Semisolid Dosage Form Product Location Distribution

        3.4.2 Players Semisolid Dosage Form Products Offered

    3.5 Market Concentration Rate Analysis

        3.5.1 Competition Landscape Analysis

        3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)

    3.6 New Products and Potential Entrants

    3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Semisolid Dosage Form by Geographic Region

    4.1 World Historic Semisolid Dosage Form Market Size by Geographic Region (2019-2024)

        4.1.1 Global Semisolid Dosage Form Annual Sales by Geographic Region (2019-2024)

        4.1.2 Global Semisolid Dosage Form Annual Revenue by Geographic Region (2019-2024)

    4.2 World Historic Semisolid Dosage Form Market Size by Country/Region (2019-2024)

        4.2.1 Global Semisolid Dosage Form Annual Sales by Country/Region (2019-2024)

        4.2.2 Global Semisolid Dosage Form Annual Revenue by Country/Region (2019-2024)

    4.3 Americas Semisolid Dosage Form Sales Growth

    4.4 APAC Semisolid Dosage Form Sales Growth

    4.5 Europe Semisolid Dosage Form Sales Growth

    4.6 Middle East & Africa Semisolid Dosage Form Sales Growth

5 Americas

    5.1 Americas Semisolid Dosage Form Sales by Country

        5.1.1 Americas Semisolid Dosage Form Sales by Country (2019-2024)

        5.1.2 Americas Semisolid Dosage Form Revenue by Country (2019-2024)

    5.2 Americas Semisolid Dosage Form Sales by Type

    5.3 Americas Semisolid Dosage Form Sales by Application

    5.4 United States

    5.5 Canada

    5.6 Mexico

    5.7 Brazil

6 APAC

    6.1 APAC Semisolid Dosage Form Sales by Region

        6.1.1 APAC Semisolid Dosage Form Sales by Region (2019-2024)

        6.1.2 APAC Semisolid Dosage Form Revenue by Region (2019-2024)

    6.2 APAC Semisolid Dosage Form Sales by Type

    6.3 APAC Semisolid Dosage Form Sales by Application

    6.4 China

    6.5 Japan

    6.6 South Korea

    6.7 Southeast Asia

    6.8 India

    6.9 Australia

    6.10 China Taiwan

7 Europe

    7.1 Europe Semisolid Dosage Form by Country

        7.1.1 Europe Semisolid Dosage Form Sales by Country (2019-2024)

        7.1.2 Europe Semisolid Dosage Form Revenue by Country (2019-2024)

    7.2 Europe Semisolid Dosage Form Sales by Type

    7.3 Europe Semisolid Dosage Form Sales by Application

    7.4 Germany

    7.5 France

    7.6 UK

    7.7 Italy

    7.8 Russia

8 Middle East & Africa

    8.1 Middle East & Africa Semisolid Dosage Form by Country

        8.1.1 Middle East & Africa Semisolid Dosage Form Sales by Country (2019-2024)

        8.1.2 Middle East & Africa Semisolid Dosage Form Revenue by Country (2019-2024)

    8.2 Middle East & Africa Semisolid Dosage Form Sales by Type

    8.3 Middle East & Africa Semisolid Dosage Form Sales by Application

    8.4 Egypt

    8.5 South Africa

    8.6 Israel

    8.7 Turkey

    8.8 GCC Countries

9 Market Drivers, Challenges and Trends

    9.1 Market Drivers & Growth Opportunities

    9.2 Market Challenges & Risks

    9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

    10.1 Raw Material and Suppliers

    10.2 Manufacturing Cost Structure Analysis of Semisolid Dosage Form

    10.3 Manufacturing Process Analysis of Semisolid Dosage Form

    10.4 Industry Chain Structure of Semisolid Dosage Form

11 Marketing, Distributors and Customer

    11.1 Sales Channel

        11.1.1 Direct Channels

        11.1.2 Indirect Channels

    11.2 Semisolid Dosage Form Distributors

    11.3 Semisolid Dosage Form Customer

12 World Forecast Review for Semisolid Dosage Form by Geographic Region

    12.1 Global Semisolid Dosage Form Market Size Forecast by Region

        12.1.1 Global Semisolid Dosage Form Forecast by Region (2025-2030)

        12.1.2 Global Semisolid Dosage Form Annual Revenue Forecast by Region (2025-2030)

    12.2 Americas Forecast by Country

    12.3 APAC Forecast by Region

    12.4 Europe Forecast by Country

    12.5 Middle East & Africa Forecast by Country

    12.6 Global Semisolid Dosage Form Forecast by Type

    12.7 Global Semisolid Dosage Form Forecast by Application

13 Key Players Analysis

    13.1 Johnson & Johnson

        13.1.1 Johnson & Johnson Company Information

        13.1.2 Johnson & Johnson Semisolid Dosage Form Product Portfolios and Specifications

        13.1.3 Johnson & Johnson Semisolid Dosage Form Sales, Revenue, Price and Gross Margin (2019-2024)

        13.1.4 Johnson & Johnson Main Business Overview

        13.1.5 Johnson & Johnson Latest Developments

    13.2 Merck & Co

        13.2.1 Merck & Co Company Information

        13.2.2 Merck & Co Semisolid Dosage Form Product Portfolios and Specifications

        13.2.3 Merck & Co Semisolid Dosage Form Sales, Revenue, Price and Gross Margin (2019-2024)

        13.2.4 Merck & Co Main Business Overview

        13.2.5 Merck & Co Latest Developments

    13.3 Bayer AG

        13.3.1 Bayer AG Company Information

        13.3.2 Bayer AG Semisolid Dosage Form Product Portfolios and Specifications

        13.3.3 Bayer AG Semisolid Dosage Form Sales, Revenue, Price and Gross Margin (2019-2024)

        13.3.4 Bayer AG Main Business Overview

        13.3.5 Bayer AG Latest Developments

    13.4 Hisamitsu Pharmaceutical

        13.4.1 Hisamitsu Pharmaceutical Company Information

        13.4.2 Hisamitsu Pharmaceutical Semisolid Dosage Form Product Portfolios and Specifications

        13.4.3 Hisamitsu Pharmaceutical Semisolid Dosage Form Sales, Revenue, Price and Gross Margin (2019-2024)

        13.4.4 Hisamitsu Pharmaceutical Main Business Overview

        13.4.5 Hisamitsu Pharmaceutical Latest Developments

    13.5 Glenmark Pharmaceuticals

        13.5.1 Glenmark Pharmaceuticals Company Information

        13.5.2 Glenmark Pharmaceuticals Semisolid Dosage Form Product Portfolios and Specifications

        13.5.3 Glenmark Pharmaceuticals Semisolid Dosage Form Sales, Revenue, Price and Gross Margin (2019-2024)

        13.5.4 Glenmark Pharmaceuticals Main Business Overview

        13.5.5 Glenmark Pharmaceuticals Latest Developments

    13.6 Cipla Ltd

        13.6.1 Cipla Ltd Company Information

        13.6.2 Cipla Ltd Semisolid Dosage Form Product Portfolios and Specifications

        13.6.3 Cipla Ltd Semisolid Dosage Form Sales, Revenue, Price and Gross Margin (2019-2024)

        13.6.4 Cipla Ltd Main Business Overview

        13.6.5 Cipla Ltd Latest Developments

    13.7 Nestlé SA

        13.7.1 Nestlé SA Company Information

        13.7.2 Nestlé SA Semisolid Dosage Form Product Portfolios and Specifications

        13.7.3 Nestlé SA Semisolid Dosage Form Sales, Revenue, Price and Gross Margin (2019-2024)

        13.7.4 Nestlé SA Main Business Overview

        13.7.5 Nestlé SA Latest Developments

    13.8 Novartis AG

        13.8.1 Novartis AG Company Information

        13.8.2 Novartis AG Semisolid Dosage Form Product Portfolios and Specifications

        13.8.3 Novartis AG Semisolid Dosage Form Sales, Revenue, Price and Gross Margin (2019-2024)

        13.8.4 Novartis AG Main Business Overview

        13.8.5 Novartis AG Latest Developments

    13.9 GlaxoSmithKline plc

        13.9.1 GlaxoSmithKline plc Company Information

        13.9.2 GlaxoSmithKline plc Semisolid Dosage Form Product Portfolios and Specifications

        13.9.3 GlaxoSmithKline plc Semisolid Dosage Form Sales, Revenue, Price and Gross Margin (2019-2024)

        13.9.4 GlaxoSmithKline plc Main Business Overview

        13.9.5 GlaxoSmithKline plc Latest Developments

    13.10 Bausch Health Companies

        13.10.1 Bausch Health Companies Company Information

        13.10.2 Bausch Health Companies Semisolid Dosage Form Product Portfolios and Specifications

        13.10.3 Bausch Health Companies Semisolid Dosage Form Sales, Revenue, Price and Gross Margin (2019-2024)

        13.10.4 Bausch Health Companies Main Business Overview

        13.10.5 Bausch Health Companies Latest Developments

    13.11 Allergan

        13.11.1 Allergan Company Information

        13.11.2 Allergan Semisolid Dosage Form Product Portfolios and Specifications

        13.11.3 Allergan Semisolid Dosage Form Sales, Revenue, Price and Gross Margin (2019-2024)

        13.11.4 Allergan Main Business Overview

        13.11.5 Allergan Latest Developments

    13.12 Biofrontera, Inc.

        13.12.1 Biofrontera, Inc. Company Information

        13.12.2 Biofrontera, Inc. Semisolid Dosage Form Product Portfolios and Specifications

        13.12.3 Biofrontera, Inc. Semisolid Dosage Form Sales, Revenue, Price and Gross Margin (2019-2024)

        13.12.4 Biofrontera, Inc. Main Business Overview

        13.12.5 Biofrontera, Inc. Latest Developments

    13.13 Crown Laboratories Inc.

        13.13.1 Crown Laboratories Inc. Company Information

        13.13.2 Crown Laboratories Inc. Semisolid Dosage Form Product Portfolios and Specifications

        13.13.3 Crown Laboratories Inc. Semisolid Dosage Form Sales, Revenue, Price and Gross Margin (2019-2024)

        13.13.4 Crown Laboratories Inc. Main Business Overview

        13.13.5 Crown Laboratories Inc. Latest Developments

    13.14 Akorn Inc. (US)

        13.14.1 Akorn Inc. (US) Company Information

        13.14.2 Akorn Inc. (US) Semisolid Dosage Form Product Portfolios and Specifications

        13.14.3 Akorn Inc. (US) Semisolid Dosage Form Sales, Revenue, Price and Gross Margin (2019-2024)

        13.14.4 Akorn Inc. (US) Main Business Overview

        13.14.5 Akorn Inc. (US) Latest Developments

    13.15 Ingenus Pharmaceuticals

        13.15.1 Ingenus Pharmaceuticals Company Information

        13.15.2 Ingenus Pharmaceuticals Semisolid Dosage Form Product Portfolios and Specifications

        13.15.3 Ingenus Pharmaceuticals Semisolid Dosage Form Sales, Revenue, Price and Gross Margin (2019-2024)

        13.15.4 Ingenus Pharmaceuticals Main Business Overview

        13.15.5 Ingenus Pharmaceuticals Latest Developments

    13.16 Sun Pharmaceuticals

        13.16.1 Sun Pharmaceuticals Company Information

        13.16.2 Sun Pharmaceuticals Semisolid Dosage Form Product Portfolios and Specifications

        13.16.3 Sun Pharmaceuticals Semisolid Dosage Form Sales, Revenue, Price and Gross Margin (2019-2024)

        13.16.4 Sun Pharmaceuticals Main Business Overview

        13.16.5 Sun Pharmaceuticals Latest Developments

    13.17 Crescita Therapeutics Inc.

        13.17.1 Crescita Therapeutics Inc. Company Information

        13.17.2 Crescita Therapeutics Inc. Semisolid Dosage Form Product Portfolios and Specifications

        13.17.3 Crescita Therapeutics Inc. Semisolid Dosage Form Sales, Revenue, Price and Gross Margin (2019-2024)

        13.17.4 Crescita Therapeutics Inc. Main Business Overview

        13.17.5 Crescita Therapeutics Inc. Latest Developments

    13.18 Mylan N.V.

        13.18.1 Mylan N.V. Company Information

        13.18.2 Mylan N.V. Semisolid Dosage Form Product Portfolios and Specifications

        13.18.3 Mylan N.V. Semisolid Dosage Form Sales, Revenue, Price and Gross Margin (2019-2024)

        13.18.4 Mylan N.V. Main Business Overview

        13.18.5 Mylan N.V. Latest Developments

    13.19 Encore Dermatology, Inc.

        13.19.1 Encore Dermatology, Inc. Company Information

        13.19.2 Encore Dermatology, Inc. Semisolid Dosage Form Product Portfolios and Specifications

        13.19.3 Encore Dermatology, Inc. Semisolid Dosage Form Sales, Revenue, Price and Gross Margin (2019-2024)

        13.19.4 Encore Dermatology, Inc. Main Business Overview

        13.19.5 Encore Dermatology, Inc. Latest Developments

    13.20 LEO Pharma

        13.20.1 LEO Pharma Company Information

        13.20.2 LEO Pharma Semisolid Dosage Form Product Portfolios and Specifications

        13.20.3 LEO Pharma Semisolid Dosage Form Sales, Revenue, Price and Gross Margin (2019-2024)

        13.20.4 LEO Pharma Main Business Overview

        13.20.5 LEO Pharma Latest Developments

    13.21 Almirall, S.A

        13.21.1 Almirall, S.A Company Information

        13.21.2 Almirall, S.A Semisolid Dosage Form Product Portfolios and Specifications

        13.21.3 Almirall, S.A Semisolid Dosage Form Sales, Revenue, Price and Gross Margin (2019-2024)

        13.21.4 Almirall, S.A Main Business Overview

        13.21.5 Almirall, S.A Latest Developments

    13.22 Aclaris Therapeutics, Inc.

        13.22.1 Aclaris Therapeutics, Inc. Company Information

        13.22.2 Aclaris Therapeutics, Inc. Semisolid Dosage Form Product Portfolios and Specifications

        13.22.3 Aclaris Therapeutics, Inc. Semisolid Dosage Form Sales, Revenue, Price and Gross Margin (2019-2024)

        13.22.4 Aclaris Therapeutics, Inc. Main Business Overview

        13.22.5 Aclaris Therapeutics, Inc. Latest Developments

    13.23 Taro Pharmaceutical Industries Ltd.

        13.23.1 Taro Pharmaceutical Industries Ltd. Company Information

        13.23.2 Taro Pharmaceutical Industries Ltd. Semisolid Dosage Form Product Portfolios and Specifications

        13.23.3 Taro Pharmaceutical Industries Ltd. Semisolid Dosage Form Sales, Revenue, Price and Gross Margin (2019-2024)

        13.23.4 Taro Pharmaceutical Industries Ltd. Main Business Overview

        13.23.5 Taro Pharmaceutical Industries Ltd. Latest Developments

    13.24 Teligent Pharma

        13.24.1 Teligent Pharma Company Information

        13.24.2 Teligent Pharma Semisolid Dosage Form Product Portfolios and Specifications

        13.24.3 Teligent Pharma Semisolid Dosage Form Sales, Revenue, Price and Gross Margin (2019-2024)

        13.24.4 Teligent Pharma Main Business Overview

        13.24.5 Teligent Pharma Latest Developments

    13.25 Perrigo Pharma

        13.25.1 Perrigo Pharma Company Information

        13.25.2 Perrigo Pharma Semisolid Dosage Form Product Portfolios and Specifications

        13.25.3 Perrigo Pharma Semisolid Dosage Form Sales, Revenue, Price and Gross Margin (2019-2024)

        13.25.4 Perrigo Pharma Main Business Overview

        13.25.5 Perrigo Pharma Latest Developments

14 Research Findings and Conclusion

List of Tables

    Table 1. Semisolid Dosage Form Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)

    Table 2. Semisolid Dosage Form Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)

    Table 3. Major Players of Ointments

    Table 4. Major Players of Pastes

    Table 5. Major Players of Plasters

    Table 6. Major Players of Gels

    Table 7. Major Players of Rigid Foams

    Table 8. Global Semisolid Dosage Form Sales by Type (2019-2024) & (K MT)

    Table 9. Global Semisolid Dosage Form Sales Market Share by Type (2019-2024)

    Table 10. Global Semisolid Dosage Form Revenue by Type (2019-2024) & ($ million)

    Table 11. Global Semisolid Dosage Form Revenue Market Share by Type (2019-2024)

    Table 12. Global Semisolid Dosage Form Sale Price by Type (2019-2024) & (USD/MT)

    Table 13. Global Semisolid Dosage Form Sales by Application (2019-2024) & (K MT)

    Table 14. Global Semisolid Dosage Form Sales Market Share by Application (2019-2024)

    Table 15. Global Semisolid Dosage Form Revenue by Application (2019-2024)

    Table 16. Global Semisolid Dosage Form Revenue Market Share by Application (2019-2024)

    Table 17. Global Semisolid Dosage Form Sale Price by Application (2019-2024) & (USD/MT)

    Table 18. Global Semisolid Dosage Form Sales by Company (2019-2024) & (K MT)

    Table 19. Global Semisolid Dosage Form Sales Market Share by Company (2019-2024)

    Table 20. Global Semisolid Dosage Form Revenue by Company (2019-2024) ($ Millions)

    Table 21. Global Semisolid Dosage Form Revenue Market Share by Company (2019-2024)

    Table 22. Global Semisolid Dosage Form Sale Price by Company (2019-2024) & (USD/MT)

    Table 23. Key Manufacturers Semisolid Dosage Form Producing Area Distribution and Sales Area

    Table 24. Players Semisolid Dosage Form Products Offered

    Table 25. Semisolid Dosage Form Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)

    Table 26. New Products and Potential Entrants

    Table 27. Mergers & Acquisitions, Expansion

    Table 28. Global Semisolid Dosage Form Sales by Geographic Region (2019-2024) & (K MT)

    Table 29. Global Semisolid Dosage Form Sales Market Share Geographic Region (2019-2024)

    Table 30. Global Semisolid Dosage Form Revenue by Geographic Region (2019-2024) & ($ millions)

    Table 31. Global Semisolid Dosage Form Revenue Market Share by Geographic Region (2019-2024)

    Table 32. Global Semisolid Dosage Form Sales by Country/Region (2019-2024) & (K MT)

    Table 33. Global Semisolid Dosage Form Sales Market Share by Country/Region (2019-2024)

    Table 34. Global Semisolid Dosage Form Revenue by Country/Region (2019-2024) & ($ millions)

    Table 35. Global Semisolid Dosage Form Revenue Market Share by Country/Region (2019-2024)

    Table 36. Americas Semisolid Dosage Form Sales by Country (2019-2024) & (K MT)

    Table 37. Americas Semisolid Dosage Form Sales Market Share by Country (2019-2024)

    Table 38. Americas Semisolid Dosage Form Revenue by Country (2019-2024) & ($ Millions)

    Table 39. Americas Semisolid Dosage Form Revenue Market Share by Country (2019-2024)

    Table 40. Americas Semisolid Dosage Form Sales by Type (2019-2024) & (K MT)

    Table 41. Americas Semisolid Dosage Form Sales by Application (2019-2024) & (K MT)

    Table 42. APAC Semisolid Dosage Form Sales by Region (2019-2024) & (K MT)

    Table 43. APAC Semisolid Dosage Form Sales Market Share by Region (2019-2024)

    Table 44. APAC Semisolid Dosage Form Revenue by Region (2019-2024) & ($ Millions)

    Table 45. APAC Semisolid Dosage Form Revenue Market Share by Region (2019-2024)

    Table 46. APAC Semisolid Dosage Form Sales by Type (2019-2024) & (K MT)

    Table 47. APAC Semisolid Dosage Form Sales by Application (2019-2024) & (K MT)

    Table 48. Europe Semisolid Dosage Form Sales by Country (2019-2024) & (K MT)

    Table 49. Europe Semisolid Dosage Form Sales Market Share by Country (2019-2024)

    Table 50. Europe Semisolid Dosage Form Revenue by Country (2019-2024) & ($ Millions)

    Table 51. Europe Semisolid Dosage Form Revenue Market Share by Country (2019-2024)

    Table 52. Europe Semisolid Dosage Form Sales by Type (2019-2024) & (K MT)

    Table 53. Europe Semisolid Dosage Form Sales by Application (2019-2024) & (K MT)

    Table 54. Middle East & Africa Semisolid Dosage Form Sales by Country (2019-2024) & (K MT)

    Table 55. Middle East & Africa Semisolid Dosage Form Sales Market Share by Country (2019-2024)

    Table 56. Middle East & Africa Semisolid Dosage Form Revenue by Country (2019-2024) & ($ Millions)

    Table 57. Middle East & Africa Semisolid Dosage Form Revenue Market Share by Country (2019-2024)

    Table 58. Middle East & Africa Semisolid Dosage Form Sales by Type (2019-2024) & (K MT)

    Table 59. Middle East & Africa Semisolid Dosage Form Sales by Application (2019-2024) & (K MT)

    Table 60. Key Market Drivers & Growth Opportunities of Semisolid Dosage Form

    Table 61. Key Market Challenges & Risks of Semisolid Dosage Form

    Table 62. Key Industry Trends of Semisolid Dosage Form

    Table 63. Semisolid Dosage Form Raw Material

    Table 64. Key Suppliers of Raw Materials

    Table 65. Semisolid Dosage Form Distributors List

    Table 66. Semisolid Dosage Form Customer List

    Table 67. Global Semisolid Dosage Form Sales Forecast by Region (2025-2030) & (K MT)

    Table 68. Global Semisolid Dosage Form Revenue Forecast by Region (2025-2030) & ($ millions)

    Table 69. Americas Semisolid Dosage Form Sales Forecast by Country (2025-2030) & (K MT)

    Table 70. Americas Semisolid Dosage Form Revenue Forecast by Country (2025-2030) & ($ millions)

    Table 71. APAC Semisolid Dosage Form Sales Forecast by Region (2025-2030) & (K MT)

    Table 72. APAC Semisolid Dosage Form Revenue Forecast by Region (2025-2030) & ($ millions)

    Table 73. Europe Semisolid Dosage Form Sales Forecast by Country (2025-2030) & (K MT)

    Table 74. Europe Semisolid Dosage Form Revenue Forecast by Country (2025-2030) & ($ millions)

    Table 75. Middle East & Africa Semisolid Dosage Form Sales Forecast by Country (2025-2030) & (K MT)

    Table 76. Middle East & Africa Semisolid Dosage Form Revenue Forecast by Country (2025-2030) & ($ millions)

    Table 77. Global Semisolid Dosage Form Sales Forecast by Type (2025-2030) & (K MT)

    Table 78. Global Semisolid Dosage Form Revenue Forecast by Type (2025-2030) & ($ Millions)

    Table 79. Global Semisolid Dosage Form Sales Forecast by Application (2025-2030) & (K MT)

    Table 80. Global Semisolid Dosage Form Revenue Forecast by Application (2025-2030) & ($ Millions)

    Table 81. Johnson & Johnson Basic Information, Semisolid Dosage Form Manufacturing Base, Sales Area and Its Competitors

    Table 82. Johnson & Johnson Semisolid Dosage Form Product Portfolios and Specifications

    Table 83. Johnson & Johnson Semisolid Dosage Form Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2024)

    Table 84. Johnson & Johnson Main Business

    Table 85. Johnson & Johnson Latest Developments

    Table 86. Merck & Co Basic Information, Semisolid Dosage Form Manufacturing Base, Sales Area and Its Competitors

    Table 87. Merck & Co Semisolid Dosage Form Product Portfolios and Specifications

    Table 88. Merck & Co Semisolid Dosage Form Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2024)

    Table 89. Merck & Co Main Business

    Table 90. Merck & Co Latest Developments

    Table 91. Bayer AG Basic Information, Semisolid Dosage Form Manufacturing Base, Sales Area and Its Competitors

    Table 92. Bayer AG Semisolid Dosage Form Product Portfolios and Specifications

    Table 93. Bayer AG Semisolid Dosage Form Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2024)

    Table 94. Bayer AG Main Business

    Table 95. Bayer AG Latest Developments

    Table 96. Hisamitsu Pharmaceutical Basic Information, Semisolid Dosage Form Manufacturing Base, Sales Area and Its Competitors

    Table 97. Hisamitsu Pharmaceutical Semisolid Dosage Form Product Portfolios and Specifications

    Table 98. Hisamitsu Pharmaceutical Semisolid Dosage Form Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2024)

    Table 99. Hisamitsu Pharmaceutical Main Business

    Table 100. Hisamitsu Pharmaceutical Latest Developments

    Table 101. Glenmark Pharmaceuticals Basic Information, Semisolid Dosage Form Manufacturing Base, Sales Area and Its Competitors

    Table 102. Glenmark Pharmaceuticals Semisolid Dosage Form Product Portfolios and Specifications

    Table 103. Glenmark Pharmaceuticals Semisolid Dosage Form Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2024)

    Table 104. Glenmark Pharmaceuticals Main Business

    Table 105. Glenmark Pharmaceuticals Latest Developments

    Table 106. Cipla Ltd Basic Information, Semisolid Dosage Form Manufacturing Base, Sales Area and Its Competitors

    Table 107. Cipla Ltd Semisolid Dosage Form Product Portfolios and Specifications

    Table 108. Cipla Ltd Semisolid Dosage Form Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2024)

    Table 109. Cipla Ltd Main Business

    Table 110. Cipla Ltd Latest Developments

    Table 111. Nestlé SA Basic Information, Semisolid Dosage Form Manufacturing Base, Sales Area and Its Competitors

    Table 112. Nestlé SA Semisolid Dosage Form Product Portfolios and Specifications

    Table 113. Nestlé SA Semisolid Dosage Form Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2024)

    Table 114. Nestlé SA Main Business

    Table 115. Nestlé SA Latest Developments

    Table 116. Novartis AG Basic Information, Semisolid Dosage Form Manufacturing Base, Sales Area and Its Competitors

    Table 117. Novartis AG Semisolid Dosage Form Product Portfolios and Specifications

    Table 118. Novartis AG Semisolid Dosage Form Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2024)

    Table 119. Novartis AG Main Business

    Table 120. Novartis AG Latest Developments

    Table 121. GlaxoSmithKline plc Basic Information, Semisolid Dosage Form Manufacturing Base, Sales Area and Its Competitors

    Table 122. GlaxoSmithKline plc Semisolid Dosage Form Product Portfolios and Specifications

    Table 123. GlaxoSmithKline plc Semisolid Dosage Form Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2024)

    Table 124. GlaxoSmithKline plc Main Business

    Table 125. GlaxoSmithKline plc Latest Developments

    Table 126. Bausch Health Companies Basic Information, Semisolid Dosage Form Manufacturing Base, Sales Area and Its Competitors

    Table 127. Bausch Health Companies Semisolid Dosage Form Product Portfolios and Specifications

    Table 128. Bausch Health Companies Semisolid Dosage Form Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2024)

    Table 129. Bausch Health Companies Main Business

    Table 130. Bausch Health Companies Latest Developments

    Table 131. Allergan Basic Information, Semisolid Dosage Form Manufacturing Base, Sales Area and Its Competitors

    Table 132. Allergan Semisolid Dosage Form Product Portfolios and Specifications

    Table 133. Allergan Semisolid Dosage Form Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2024)

    Table 134. Allergan Main Business

    Table 135. Allergan Latest Developments

    Table 136. Biofrontera, Inc. Basic Information, Semisolid Dosage Form Manufacturing Base, Sales Area and Its Competitors

    Table 137. Biofrontera, Inc. Semisolid Dosage Form Product Portfolios and Specifications

    Table 138. Biofrontera, Inc. Semisolid Dosage Form Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2024)

    Table 139. Biofrontera, Inc. Main Business

    Table 140. Biofrontera, Inc. Latest Developments

    Table 141. Crown Laboratories Inc. Basic Information, Semisolid Dosage Form Manufacturing Base, Sales Area and Its Competitors

    Table 142. Crown Laboratories Inc. Semisolid Dosage Form Product Portfolios and Specifications

    Table 143. Crown Laboratories Inc. Semisolid Dosage Form Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2024)

    Table 144. Crown Laboratories Inc. Main Business

    Table 145. Crown Laboratories Inc. Latest Developments

    Table 146. Akorn Inc. (US) Basic Information, Semisolid Dosage Form Manufacturing Base, Sales Area and Its Competitors

    Table 147. Akorn Inc. (US) Semisolid Dosage Form Product Portfolios and Specifications

    Table 148. Akorn Inc. (US) Semisolid Dosage Form Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2024)

    Table 149. Akorn Inc. (US) Main Business

    Table 150. Akorn Inc. (US) Latest Developments

    Table 151. Ingenus Pharmaceuticals Basic Information, Semisolid Dosage Form Manufacturing Base, Sales Area and Its Competitors

    Table 152. Ingenus Pharmaceuticals Semisolid Dosage Form Product Portfolios and Specifications

    Table 153. Ingenus Pharmaceuticals Semisolid Dosage Form Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2024)

    Table 154. Ingenus Pharmaceuticals Main Business

    Table 155. Ingenus Pharmaceuticals Latest Developments

    Table 156. Sun Pharmaceuticals Basic Information, Semisolid Dosage Form Manufacturing Base, Sales Area and Its Competitors

    Table 157. Sun Pharmaceuticals Semisolid Dosage Form Product Portfolios and Specifications

    Table 158. Sun Pharmaceuticals Semisolid Dosage Form Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2024)

    Table 159. Sun Pharmaceuticals Main Business

    Table 160. Sun Pharmaceuticals Latest Developments

    Table 161. Crescita Therapeutics Inc. Basic Information, Semisolid Dosage Form Manufacturing Base, Sales Area and Its Competitors

    Table 162. Crescita Therapeutics Inc. Semisolid Dosage Form Product Portfolios and Specifications

    Table 163. Crescita Therapeutics Inc. Semisolid Dosage Form Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2024)

    Table 164. Crescita Therapeutics Inc. Main Business

    Table 165. Crescita Therapeutics Inc. Latest Developments

    Table 166. Mylan N.V. Basic Information, Semisolid Dosage Form Manufacturing Base, Sales Area and Its Competitors

    Table 167. Mylan N.V. Semisolid Dosage Form Product Portfolios and Specifications

    Table 168. Mylan N.V. Semisolid Dosage Form Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2024)

    Table 169. Mylan N.V. Main Business

    Table 170. Mylan N.V. Latest Developments

    Table 171. Encore Dermatology, Inc. Basic Information, Semisolid Dosage Form Manufacturing Base, Sales Area and Its Competitors

    Table 172. Encore Dermatology, Inc. Semisolid Dosage Form Product Portfolios and Specifications

    Table 173. Encore Dermatology, Inc. Semisolid Dosage Form Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2024)

    Table 174. Encore Dermatology, Inc. Main Business

    Table 175. Encore Dermatology, Inc. Latest Developments

    Table 176. LEO Pharma Basic Information, Semisolid Dosage Form Manufacturing Base, Sales Area and Its Competitors

    Table 177. LEO Pharma Semisolid Dosage Form Product Portfolios and Specifications

    Table 178. LEO Pharma Semisolid Dosage Form Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2024)

    Table 179. LEO Pharma Main Business

    Table 180. LEO Pharma Latest Developments

    Table 181. Almirall, S.A Basic Information, Semisolid Dosage Form Manufacturing Base, Sales Area and Its Competitors

    Table 182. Almirall, S.A Semisolid Dosage Form Product Portfolios and Specifications

    Table 183. Almirall, S.A Semisolid Dosage Form Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2024)

    Table 184. Almirall, S.A Main Business

    Table 185. Almirall, S.A Latest Developments

    Table 186. Aclaris Therapeutics, Inc. Basic Information, Semisolid Dosage Form Manufacturing Base, Sales Area and Its Competitors

    Table 187. Aclaris Therapeutics, Inc. Semisolid Dosage Form Product Portfolios and Specifications

    Table 188. Aclaris Therapeutics, Inc. Semisolid Dosage Form Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2024)

    Table 189. Aclaris Therapeutics, Inc. Main Business

    Table 190. Aclaris Therapeutics, Inc. Latest Developments

    Table 191. Taro Pharmaceutical Industries Ltd. Basic Information, Semisolid Dosage Form Manufacturing Base, Sales Area and Its Competitors

    Table 192. Taro Pharmaceutical Industries Ltd. Semisolid Dosage Form Product Portfolios and Specifications

    Table 193. Taro Pharmaceutical Industries Ltd. Semisolid Dosage Form Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2024)

    Table 194. Taro Pharmaceutical Industries Ltd. Main Business

    Table 195. Taro Pharmaceutical Industries Ltd. Latest Developments

    Table 196. Teligent Pharma Basic Information, Semisolid Dosage Form Manufacturing Base, Sales Area and Its Competitors

    Table 197. Teligent Pharma Semisolid Dosage Form Product Portfolios and Specifications

    Table 198. Teligent Pharma Semisolid Dosage Form Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2024)

    Table 199. Teligent Pharma Main Business

    Table 200. Teligent Pharma Latest Developments

    Table 201. Perrigo Pharma Basic Information, Semisolid Dosage Form Manufacturing Base, Sales Area and Its Competitors

    Table 202. Perrigo Pharma Semisolid Dosage Form Product Portfolios and Specifications

    Table 203. Perrigo Pharma Semisolid Dosage Form Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2024)

    Table 204. Perrigo Pharma Main Business

    Table 205. Perrigo Pharma Latest Developments

List of Figures

    Figure 1. Picture of Semisolid Dosage Form

    Figure 2. Semisolid Dosage Form Report Years Considered

    Figure 3. Research Objectives

    Figure 4. Research Methodology

    Figure 5. Research Process and Data Source

    Figure 6. Global Semisolid Dosage Form Sales Growth Rate 2019-2030 (K MT)

    Figure 7. Global Semisolid Dosage Form Revenue Growth Rate 2019-2030 ($ Millions)

    Figure 8. Semisolid Dosage Form Sales by Region (2019, 2023 & 2030) & ($ Millions)

    Figure 9. Product Picture of Ointments

    Figure 10. Product Picture of Pastes

    Figure 11. Product Picture of Plasters

    Figure 12. Product Picture of Gels

    Figure 13. Product Picture of Rigid Foams

    Figure 14. Global Semisolid Dosage Form Sales Market Share by Type in 2023

    Figure 15. Global Semisolid Dosage Form Revenue Market Share by Type (2019-2024)

    Figure 16. Semisolid Dosage Form Consumed in Skin

    Figure 17. Global Semisolid Dosage Form Market: Skin (2019-2024) & (K MT)

    Figure 18. Semisolid Dosage Form Consumed in Nasal Cavity

    Figure 19. Global Semisolid Dosage Form Market: Nasal Cavity (2019-2024) & (K MT)

    Figure 20. Semisolid Dosage Form Consumed in Vaginal Cavity

    Figure 21. Global Semisolid Dosage Form Market: Vaginal Cavity (2019-2024) & (K MT)

    Figure 22. Semisolid Dosage Form Consumed in Rectal Cavity

    Figure 23. Global Semisolid Dosage Form Market: Rectal Cavity (2019-2024) & (K MT)

    Figure 24. Semisolid Dosage Form Consumed in Others

    Figure 25. Global Semisolid Dosage Form Market: Others (2019-2024) & (K MT)

    Figure 26. Global Semisolid Dosage Form Sales Market Share by Application (2023)

    Figure 27. Global Semisolid Dosage Form Revenue Market Share by Application in 2023

    Figure 28. Semisolid Dosage Form Sales Market by Company in 2023 (K MT)

    Figure 29. Global Semisolid Dosage Form Sales Market Share by Company in 2023

    Figure 30. Semisolid Dosage Form Revenue Market by Company in 2023 ($ Million)

    Figure 31. Global Semisolid Dosage Form Revenue Market Share by Company in 2023

    Figure 32. Global Semisolid Dosage Form Sales Market Share by Geographic Region (2019-2024)

    Figure 33. Global Semisolid Dosage Form Revenue Market Share by Geographic Region in 2023

    Figure 34. Americas Semisolid Dosage Form Sales 2019-2024 (K MT)

    Figure 35. Americas Semisolid Dosage Form Revenue 2019-2024 ($ Millions)

    Figure 36. APAC Semisolid Dosage Form Sales 2019-2024 (K MT)

    Figure 37. APAC Semisolid Dosage Form Revenue 2019-2024 ($ Millions)

    Figure 38. Europe Semisolid Dosage Form Sales 2019-2024 (K MT)

    Figure 39. Europe Semisolid Dosage Form Revenue 2019-2024 ($ Millions)

    Figure 40. Middle East & Africa Semisolid Dosage Form Sales 2019-2024 (K MT)

    Figure 41. Middle East & Africa Semisolid Dosage Form Revenue 2019-2024 ($ Millions)

    Figure 42. Americas Semisolid Dosage Form Sales Market Share by Country in 2023

    Figure 43. Americas Semisolid Dosage Form Revenue Market Share by Country in 2023

    Figure 44. Americas Semisolid Dosage Form Sales Market Share by Type (2019-2024)

    Figure 45. Americas Semisolid Dosage Form Sales Market Share by Application (2019-2024)

    Figure 46. United States Semisolid Dosage Form Revenue Growth 2019-2024 ($ Millions)

    Figure 47. Canada Semisolid Dosage Form Revenue Growth 2019-2024 ($ Millions)

    Figure 48. Mexico Semisolid Dosage Form Revenue Growth 2019-2024 ($ Millions)

    Figure 49. Brazil Semisolid Dosage Form Revenue Growth 2019-2024 ($ Millions)

    Figure 50. APAC Semisolid Dosage Form Sales Market Share by Region in 2023

    Figure 51. APAC Semisolid Dosage Form Revenue Market Share by Regions in 2023

    Figure 52. APAC Semisolid Dosage Form Sales Market Share by Type (2019-2024)

    Figure 53. APAC Semisolid Dosage Form Sales Market Share by Application (2019-2024)

    Figure 54. China Semisolid Dosage Form Revenue Growth 2019-2024 ($ Millions)

    Figure 55. Japan Semisolid Dosage Form Revenue Growth 2019-2024 ($ Millions)

    Figure 56. South Korea Semisolid Dosage Form Revenue Growth 2019-2024 ($ Millions)

    Figure 57. Southeast Asia Semisolid Dosage Form Revenue Growth 2019-2024 ($ Millions)

    Figure 58. India Semisolid Dosage Form Revenue Growth 2019-2024 ($ Millions)

    Figure 59. Australia Semisolid Dosage Form Revenue Growth 2019-2024 ($ Millions)

    Figure 60. China Taiwan Semisolid Dosage Form Revenue Growth 2019-2024 ($ Millions)

    Figure 61. Europe Semisolid Dosage Form Sales Market Share by Country in 2023

    Figure 62. Europe Semisolid Dosage Form Revenue Market Share by Country in 2023

    Figure 63. Europe Semisolid Dosage Form Sales Market Share by Type (2019-2024)

    Figure 64. Europe Semisolid Dosage Form Sales Market Share by Application (2019-2024)

    Figure 65. Germany Semisolid Dosage Form Revenue Growth 2019-2024 ($ Millions)

    Figure 66. France Semisolid Dosage Form Revenue Growth 2019-2024 ($ Millions)

    Figure 67. UK Semisolid Dosage Form Revenue Growth 2019-2024 ($ Millions)

    Figure 68. Italy Semisolid Dosage Form Revenue Growth 2019-2024 ($ Millions)

    Figure 69. Russia Semisolid Dosage Form Revenue Growth 2019-2024 ($ Millions)

    Figure 70. Middle East & Africa Semisolid Dosage Form Sales Market Share by Country in 2023

    Figure 71. Middle East & Africa Semisolid Dosage Form Revenue Market Share by Country in 2023

    Figure 72. Middle East & Africa Semisolid Dosage Form Sales Market Share by Type (2019-2024)

    Figure 73. Middle East & Africa Semisolid Dosage Form Sales Market Share by Application (2019-2024)

    Figure 74. Egypt Semisolid Dosage Form Revenue Growth 2019-2024 ($ Millions)

    Figure 75. South Africa Semisolid Dosage Form Revenue Growth 2019-2024 ($ Millions)

    Figure 76. Israel Semisolid Dosage Form Revenue Growth 2019-2024 ($ Millions)

    Figure 77. Turkey Semisolid Dosage Form Revenue Growth 2019-2024 ($ Millions)

    Figure 78. GCC Country Semisolid Dosage Form Revenue Growth 2019-2024 ($ Millions)

    Figure 79. Manufacturing Cost Structure Analysis of Semisolid Dosage Form in 2023

    Figure 80. Manufacturing Process Analysis of Semisolid Dosage Form

    Figure 81. Industry Chain Structure of Semisolid Dosage Form

    Figure 82. Channels of Distribution

    Figure 83. Global Semisolid Dosage Form Sales Market Forecast by Region (2025-2030)

    Figure 84. Global Semisolid Dosage Form Revenue Market Share Forecast by Region (2025-2030)

    Figure 85. Global Semisolid Dosage Form Sales Market Share Forecast by Type (2025-2030)

    Figure 86. Global Semisolid Dosage Form Revenue Market Share Forecast by Type (2025-2030)

    Figure 87. Global Semisolid Dosage Form Sales Market Share Forecast by Application (2025-2030)

    Figure 88. Global Semisolid Dosage Form Revenue Market Share Forecast by Application (2025-2030)

Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
"Johnson & Johnson"|||"Merck & Co"|||"Bayer AG"|||"Hisamitsu Pharmaceutical"|||"Glenmark Pharmaceuticals"|||"Cipla Ltd"|||"Nestlé SA"|||"Novartis AG"|||"GlaxoSmithKline plc"|||"Bausch Health Companies"|||"Allergan"|||"Biofrontera|||Inc."|||"Crown Laboratories Inc."|||"Akorn Inc."|||"Ingenus Pharmaceuticals"|||"Sun Pharmaceuticals"|||"Crescita Therapeutics Inc."|||"Mylan N.V."|||"Encore Dermatology|||Inc."|||"LEO Pharma"|||"Almirall|||S.A"|||"Aclaris Therapeutics|||Inc."|||"Taro Pharmaceutical Industries Ltd."|||"Teligent Pharma"|||"Perrigo Pharma"

Frequently Asked Questions

What is the USP of the report? expand_more
Semisolid Dosage Form report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
What are the key content of the report? expand_more
Semisolid Dosage Form report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
What are the value propositions and opportunities offered in this market research report? expand_more
Semisolid Dosage Form report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.